Evidence map›Paper›PMID 26226385›Full record

ArticlePloS one2015

Removal of Protein Capping Enhances the Antibacterial Efficiency of Biosynthesized Silver Nanoparticles.

Navin Jain, Arpit Bhargava, Mohit Rathi, R Venkataramana Dilip, Jitendra Panwar

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Archives of Razi Institute · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Evaluation of E. coli inhibition by plain and polymer-coated silver nanoparticles.Revista do Instituto de Medicina Tropical de Sao Paulo · 2018
    Article
  19. Biomimetic synthesis of AgNPs fromIET nanobiotechnology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Navin JainCentre for Biotechnology, Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, 333 031, India.
Arpit BhargavaCentre for Biotechnology, Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, 333 031, India.
Mohit RathiCentre for Biotechnology, Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, 333 031, India.
R Venkataramana DilipCentre for Biotechnology, Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, 333 031, India.
Jitendra PanwarCentre for Biotechnology, Department of Biological Sciences, Birla Institute of Technology and Science, Pilani, 333 031, India.
Birla Institute of Technology and Science, Pilani · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study demonstrates an economical and environmental affable approach for the synthesis of "protein-capped" silver nanoparticles in aqueous solvent system. A variety of standard techniques viz. UV-visible spectroscopy, transmission electron microscopy (TEM), energy dispersive spectroscopy (EDS) and X-ray diffraction (XRD) measurements were employed to characterize the shape, size and composition of nanoparticles. The synthesized nanoparticles were found to be homogenous, spherical, mono-dispersed and covered with multi-layered protein shell. In order to prepare bare silver nanoparticles, the protein shell was removed from biogenic nanoparticles as confirmed by UV-visible spectroscopy, FTIR and photoluminescence analysis. Subsequently, the antibacterial efficacy of protein-capped and bare silver nanoparticles was compared by bacterial growth rate and minimum inhibitory concentration assay. The results revealed that bare nanoparticles were more effective as compared to the protein-capped silver nanoparticles with varying antibacterial potential against the tested Gram positive and negative bacterial species. Mechanistic studies based on ROS generation and membrane damage suggested that protein-capped and bare silver nanoparticles demonstrate distinct mode of action. These findings were strengthened by the TEM imaging along with silver ion release measurements using inductively coupled plasma atomic emission spectroscopy (ICP-AES). In conclusion, our results illustrate that presence of protein shell on silver nanoparticles can decrease their bactericidal effects. These findings open new avenues for surface modifications of nanoparticles to modulate and enhance their functional properties.

Indexed as

Anti-Bacterial AgentsBacillus cereusEscherichia coliKlebsiella pneumoniaeMetal NanoparticlesMicrobial Sensitivity TestsMicroscopy, Electron, TransmissionParticle SizeProteinsPseudomonas putidaSpectrophotometry, AtomicSpectroscopy, Fourier Transform InfraredX-Ray DiffractionAnti-Bacterial AgentsProteins

Identifiers

PMID26226385
PMCPMC4520467
OpenAlexW1904569021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.